Department of Urology, University Hospital Bichat Claude Bernard, Assistance Publique Hôpitaux de Paris, University Paris VII, Paris, France.
Urology. 2013 Jan;81(1):12-5. doi: 10.1016/j.urology.2012.06.084.
To assess the quality of specimens obtained from prostate biopsies performed by urology residents and evaluate the number of procedures required to perform high-quality transrectal ultrasound (TRUS)-guided prostate biopsies.
Between 2006 and 2009, 770 patients underwent TRUS-guided prostate biopsies in our academic center. During the 6 semesters of this period, 24 residents (4 per semester) performed 1 session of 5.6±1.5 procedures each month for a total of 33.6±9 procedures during the study. The first session was performed with a senior urologist. Prostate cancer detection rate and standards of quality (average length of prostatic core biopsy specimens and absence of prostatic tissue) were retrospectively studied between the beginning and the end of each semester.
A total of 12,760 biopsy cores were performed for 770 procedures. Mean patient age (64.5±6.1 years), and median prostate-specific antigen (8.7±3.7 ng/mL) were comparable between the study periods. The average length of biopsy cores significantly improved (+10%) from the first (12±2.7 mm) to the last month (13.2±2.1 mm) with a plateau after 12 procedures. Overall, cancer detection rate was 47% and was stable during the semester (41.3% the first month vs 44.1% the last month; P=.39). On univariate and multivariate analysis the mean length of biopsy specimens was associated with the number of procedures (P<.001) and the number of cores performed (P<.001).
Twelve procedures are necessary to perform high-quality TRUS-guided prostate biopsies without compromising prostate cancer detection. In current training programs, we strongly recommend that residents have direct supervision for a minimum of 12 cases before they are allowed to perform TRUS-guided biopsies with indirect supervision.
评估泌尿科住院医师进行的前列腺活检标本的质量,并评估完成高质量经直肠超声(TRUS)引导前列腺活检所需的操作次数。
在 2006 年至 2009 年间,我们的学术中心有 770 例患者接受了 TRUS 引导下的前列腺活检。在这 6 个学期中,24 名住院医师(每学期 4 名)每月进行 1 次,每次 5.6±1.5 次,研究期间共进行 33.6±9 次。第 1 次操作由一名资深泌尿科医生进行。回顾性研究了每个学期开始和结束时前列腺癌检出率和质量标准(前列腺核心活检标本的平均长度和无前列腺组织)。
共进行了 770 例前列腺活检,共 12760 个活检芯。研究期间,患者平均年龄(64.5±6.1 岁)和中位前列腺特异性抗原(8.7±3.7ng/mL)相似。从第 1 个月(12±2.7mm)到最后 1 个月(13.2±2.1mm),活检芯的平均长度显著提高(增加 10%),12 次操作后达到平台。总的来说,癌症检出率为 47%,且在整个学期保持稳定(第 1 个月为 41.3%,最后 1 个月为 44.1%;P=.39)。单因素和多因素分析均表明,活检标本的平均长度与操作次数(P<.001)和活检芯数量(P<.001)有关。
完成高质量的 TRUS 引导前列腺活检需要 12 次操作,且不会影响前列腺癌的检出率。在当前的培训计划中,我们强烈建议住院医师在允许他们进行 TRUS 引导活检之前,接受至少 12 例直接监督的病例。